Article Information
History
- December 19, 2022.
Article Versions
- Version 1 (December 16, 2022 - 17:32).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Erica Españo1,
- Jiyeon Kim1,
- Chong-Kil Lee2,
- Robert G. Webster3,
- Richard J. Webby3 and
- Jeong-Ki Kim1,*
- 1Department of Pharmacy, Korea University College of Pharmacy, Sejong 30019, Republic of Korea
- 2Department of Pharmaceutics, College of Pharmacy, Chungbuk National University, Cheongju 28644, Republic of Korea
- 3Department of Infectious Diseases, St. Jude Children’s Research Hospital, Memphis, TN 38195, USA
- ↵*Corresponding author:
Jeong-Ki Kim: E-mail: jkfrancis{at}korea.ac.kr; Tel.: +82 44 860 1613
Posted December 19, 2022.
Chelerythrine as an anti-Zika virus agent: therapeutic potential and mode of action
